BioWorld MedTech

July 25, 2012

Despite tough times, big exits still exist for med-tech firms

Despite the belief that big exits in the device space are rare, a report from Silicon Valley Bank (SVB; Santa Clara, California) shows otherwise, offering up data that suggests there was good exit activity across multiple indications. Read More

START shows correlation between brain scan and stroke outcomes

Report from Europe: NVVP approves Hologic's Cervista HPV HR test

Washington roundup: FTC commissioner sees problem in patents for standard-setting tech

Financings roundup: Histogenics raises $49M for NeoCart and VeriCart

Coming Thursday in the MDD Interview

Agreements/contracts: Gen-Probe, Life Technologies to distribute SeCore HLA products

Deals roundup: WMG in merger plan with Winner Holding Limited

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

Elderly hands holding broken brain structure

Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

BioWorld Science

Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

Capital remains selective in ‘barbell’ biotech market

BioWorld

Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...

Brush scrubbing brain figurine with soap

PSB-229 reduces plaque burden in Alzheimer’s models

BioWorld Science

Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...